CORE--ANIMAL AND IMMUNOLOGY FACILITY

$0P60FY2002DKNIH

Washington University, Saint Louis MO

Investigators

Linked publications & trials

Paper 38956087 Paper 38804679 Paper 38712131 Paper 38344800 Paper 38284547 Paper 38167725 Paper 37773161 Paper 37506172 Paper 37415600 Paper 36952346 Paper 36824811 Paper 36712124 Paper 36042311 Paper 35013808 Paper 34986330 Paper 34984925 Paper 34792267 Paper 34425110 Paper 34185708 Paper 33915141 Paper 33910017 Paper 33894211 Paper 33869980 Paper 33684942 Paper 33674166 Paper 33638902 Paper 33543238 Paper 33214136 Paper 33164985 Paper 33122205 Paper 32651241 Paper 32632005 Paper 32518033 Paper 32366942 Paper 32253320 Paper 32233916 Paper 32099031 Paper 32060407 Paper 31978605 Paper 31805015 Paper 31773053 Paper 31606123 Paper 31588013 Paper 31472979 Paper 31471317 Paper 31454790 Paper 31422871 Paper 31352791 Paper 31303390 Paper 31110206 Paper 31004409 Paper 30979932 Paper 30914711 Paper 30900408 Paper 30663677 Paper 30607174 Paper 30260041 Paper 30224802 Paper 30094786 Paper 30054913 Paper 30028636 Paper 29945639 Paper 29850877 Paper 29687650 Paper 29657975 Paper 29634313 Paper 29487137 Paper 29478028 Paper 29476613 Paper 29464907 Paper 29321376 Paper 29230355 Paper 29180119 Paper 29130034 Paper 29086514 Paper 28938478 Paper 28930673 Paper 28719799 Paper 28637825 Paper 28604759 Paper 28597936 Paper 28512057 Paper 28479474 Paper 28473464 Paper 28468959 Paper 28295415 Paper 28245099 Paper 28212335 Paper 28183278 Paper 28130310 Paper 28003103 Paper 27992627 Paper 27899481 Paper 27806377 Paper 27797912 Paper 27739136 Paper 27732859 Paper 27718448 Paper 27615139 Paper 27588438

Abstract

This application seeks support for the establishment of an Animal/Transgenic Core Facility within the Diabetes Research and Training Center (DRTC) of the Washington University School of Medicine. This Core was proposed by the DRTC's Advisory Committee after a detailed analysis determined that a high priority should be given to support more directly rapidly growing research programs in the immunology of diabetes, islet transplantation biology and molecular biology. The facility will offer three core services: (1) provide NOD mice, (2) provide SCID mice and (3) assist in the development of transgenic mice. In addition it will provide valuable consultative and training services.

View original record on NIH RePORTER →